ENVERIC BIOSCIENCES, INC. Comprehensive Income
ENVERIC BIOSCIENCES, INC. (ENVB) reported Comprehensive Income of -$3.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$3.04M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$1.64M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$679.82K.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$3.39M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$8.76M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$9.60M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$17.49M.
- ENVERIC BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$19.31M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.04M 10-Q · filed 2026-08-14 | -$4.68M 10-Q · filed 2026-08-14 | -$5.36M derived: sum of 3 quarters · filed 2026-08-14 | -$8.75M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$1.64M 10-Q · filed 2026-05-15 | -$2.32M derived: sum of 2 quarters · filed 2026-05-15 | -$5.71M derived: sum of 3 quarters · filed 2026-05-15 | -$8.21M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$679.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$4.07M derived: sum of 2 quarters · filed 2026-03-27 | -$6.57M derived: sum of 3 quarters · filed 2026-08-14 | -$8.76M 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$3.39M 10-Q · filed 2025-11-14 | -$5.89M derived: sum of 2 quarters · filed 2026-08-14 | -$8.08M 10-Q · filed 2025-11-14 | -$11.29M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$2.49M 10-Q · filed 2026-08-14 | -$4.68M 10-Q · filed 2026-08-14 | -$7.90M derived: sum of 3 quarters · filed 2026-08-14 | -$9.95M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$2.19M 10-Q · filed 2026-05-15 | -$5.40M derived: sum of 2 quarters · filed 2026-05-15 | -$7.46M derived: sum of 3 quarters · filed 2026-05-15 | -$9.35M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$5.27M derived: sum of 2 quarters · filed 2026-03-27 | -$7.16M derived: sum of 3 quarters · filed 2026-03-27 | -$9.60M 10-K · filed 2026-03-27 | |
| 2024-09-30 | -$2.05M 10-Q · filed 2025-11-14 | -$3.95M derived: sum of 2 quarters · filed 2025-11-14 | -$6.39M 10-Q · filed 2025-11-14 | -$9.86M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$1.89M 10-Q · filed 2025-08-14 | -$4.33M 10-Q · filed 2025-08-14 | -$7.80M derived: sum of 3 quarters · filed 2025-08-14 | -$10.61M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$2.44M 10-Q · filed 2025-05-14 | -$5.91M derived: sum of 2 quarters · filed 2025-05-14 | -$8.72M derived: sum of 3 quarters · filed 2025-05-14 | -$15.13M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$6.28M derived: sum of 2 quarters · filed 2025-03-28 | -$12.69M derived: sum of 3 quarters · filed 2025-03-28 | -$17.49M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$2.81M 10-Q · filed 2024-11-14 | -$9.22M derived: sum of 2 quarters · filed 2024-11-14 | -$14.02M 10-Q · filed 2024-11-14 | -$22.72M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$6.41M 10-Q · filed 2024-08-12 | -$11.21M 10-Q · filed 2024-08-12 | -$19.91M derived: sum of 3 quarters · filed 2024-08-12 | -$22.93M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$4.80M 10-Q · filed 2024-05-15 | -$13.50M derived: sum of 2 quarters · filed 2024-05-15 | -$16.52M derived: sum of 3 quarters · filed 2024-05-15 | -$19.67M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$11.72M derived: sum of 2 quarters · filed 2024-03-26 | -$14.87M derived: sum of 3 quarters · filed 2024-03-26 | -$19.31M 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$3.02M 10-Q · filed 2023-11-13 | -$6.17M derived: sum of 2 quarters · filed 2023-11-13 | -$10.61M 10-Q · filed 2023-11-13 | -$52.56M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$3.15M 10-Q · filed 2023-08-11 | -$7.59M 10-Q · filed 2023-08-11 | -$49.54M derived: sum of 3 quarters · filed 2023-08-11 | -$52.26M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$4.44M 10-Q · filed 2023-05-15 | -$46.39M derived: sum of 2 quarters · filed 2023-06-09 | -$49.11M derived: sum of 3 quarters · filed 2023-06-09 | -$50.05M derived: sum of 4 quarters · filed 2023-06-09 | |
| 2021-12-31 | -$41.95M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-09 | -$44.67M derived: sum of 2 quarters · filed 2023-06-09 | -$45.61M derived: sum of 3 quarters · filed 2023-06-09 | -$48.83M 10-K/A · filed 2023-06-09 | |
| 2021-09-30 | -$2.72M 10-Q · filed 2022-11-14 | -$3.66M derived: sum of 2 quarters · filed 2022-11-14 | -$6.88M 10-Q · filed 2022-11-14 | -$11.40M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$941.55K 10-Q · filed 2022-08-12 | -$4.16M 10-Q · filed 2022-08-12 | -$8.68M derived: sum of 3 quarters · filed 2022-08-12 | -$9.25M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$3.21M 10-Q · filed 2022-05-13 | -$7.74M derived: sum of 2 quarters · filed 2022-05-13 | -$8.31M derived: sum of 3 quarters · filed 2022-05-13 | -$9.14M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$5.09M derived: sum of 2 quarters · filed 2022-03-31 | -$5.92M derived: sum of 3 quarters · filed 2022-03-31 | -$7.03M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$572.64K 10-Q · filed 2021-11-15 | -$1.40M derived: sum of 2 quarters · filed 2021-11-15 | -$2.51M 10-Q · filed 2021-11-15 | -$5.98M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$828.46K 10-Q · filed 2021-08-13 | -$1.94M 10-Q · filed 2021-08-13 | -$5.41M derived: sum of 3 quarters · filed 2021-08-13 | -$5.49M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | -$1.93M 10-Q · filed 2020-05-15 | -$4.58M derived: sum of 2 quarters · filed 2020-11-16 | -$4.66M derived: sum of 3 quarters · filed 2020-11-16 | -$6.04M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-12-31 | -$2.65M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-11-16 | -$2.73M derived: sum of 2 quarters · filed 2020-11-16 | -$4.11M derived: sum of 3 quarters · filed 2020-11-16 | -$6.06M 10-Q · filed 2020-11-16 | -$6.06M 10-K · filed 2020-03-25 |
| 2019-09-30 | -$83.44K 10-Q · filed 2019-11-08 | -$1.46M derived: sum of 2 quarters · filed 2019-11-08 | -$3.41M 10-Q · filed 2019-11-08 | -$23.23M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-06-30 | -$1.38M 10-Q · filed 2019-08-14 | -$3.33M 10-Q · filed 2019-08-14 | -$23.15M derived: sum of 3 quarters · filed 2020-08-12 | -$19.26M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | -$1.95M 10-Q · filed 2020-05-15 | -$21.77M derived: sum of 2 quarters · filed 2020-08-12 | -$17.88M derived: sum of 3 quarters · filed 2020-08-12 | -$19.28M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2018-12-31 | -$19.82M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | -$15.93M derived: sum of 2 quarters · filed 2020-08-12 | -$17.33M derived: sum of 3 quarters · filed 2020-08-12 | -$19.43M 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | $3.88M 10-Q · filed 2019-11-08 | $2.49M derived: sum of 2 quarters · filed 2019-11-08 | $388.69K 10-Q · filed 2019-11-08 | -$1.10M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | -$1.40M 10-Q · filed 2019-08-14 | -$3.50M 10-Q · filed 2019-08-14 | -$4.99M derived: sum of 3 quarters · filed 2019-08-14 | -$9.61M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$2.10M 10-Q · filed 2019-05-14 | -$3.59M derived: sum of 2 quarters · filed 2019-05-14 | -$8.22M derived: sum of 3 quarters · filed 2019-05-14 | -$12.00M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$6.12M derived: sum of 2 quarters · filed 2019-03-26 | -$9.90M derived: sum of 3 quarters · filed 2019-03-26 | -$11.12M 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$4.62M 10-Q · filed 2018-11-14 | -$8.41M derived: sum of 2 quarters · filed 2018-11-14 | -$9.63M 10-Q · filed 2018-11-14 | -$8.33M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$3.79M 10-Q · filed 2018-08-14 | -$5.00M 10-Q · filed 2018-08-14 | -$3.70M derived: sum of 3 quarters · filed 2018-08-14 | -$5.42M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$1.22M 10-Q · filed 2018-05-15 | $83.89K derived: sum of 2 quarters · filed 2018-05-15 | -$1.63M derived: sum of 3 quarters · filed 2018-05-15 | -$2.85M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$418.04K derived: sum of 2 quarters · filed 2018-04-02 | -$1.63M derived: sum of 3 quarters · filed 2018-04-02 | -$2.79M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$1.72M 10-Q · filed 2017-11-13 | -$2.93M derived: sum of 2 quarters · filed 2017-11-13 | -$4.09M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$1.21M 10-Q · filed 2017-08-14 | -$2.37M 10-Q · filed 2017-08-14 | |||
| 2015-12-31 | -$814.08K 10-K/A · filed 2017-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |